Answer
The subcutaneous pre-filled syringe may be self-injected after appropriate training. Intravenous risankizumab must be prepared and given by healthcare professionals.
Sources for this answer
- Skyrizi 150 mg solution for injection in pre-filled syringe — Current selected SmPCemc · Summary of Product Characteristics
- Skyrizi 600 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.